-
Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumors
Bhin, J., Paes Dias, M., Gogola, E., Rolfs, F., Piersma, S. R., de Bruijn, R., de Ruiter, J. R., van den Broek, B., Duarte, A. A., Sol, W., van der Heijden, I., Andronikou, C., Kaiponen, T. S., Bakker, L., Lieftink, C., Morris, B., Beijersbergen, R. L., van de Ven, M., Jimenez, C. R., Wessels, L. F. A., & 2 others , 30 May 2023, In: Cell reports. 42, 5, 112538.Research output: Contribution to journal › Article › Academic › peer-review
-
Phosphoproteomics After Guanidinium Thiocyanate Extraction of Tissue Biopsies
Rolfs, F., de Goeij-de Haas, R. R., Knol, J. C., Piersma, S. R. & Jimenez, C. R., 2023, In: Methods in molecular biology (Clifton, N.J.). 2718, p. 285-302 18 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers (Nature, (2022), 608, 7923, (609-617), 10.1038/s41586-022-05066-5)
Zingg, D., Bhin, J., Yemelyanenko, J., Kas, S. M., Rolfs, F., Lutz, C., Lee, J. K., Klarenbeek, S., Silverman, I. M., Annunziato, S., Chan, C. S., Piersma, S. R., Eijkman, T., Badoux, M., Gogola, E., Siteur, B., Sprengers, J., de Klein, B., de Goeij-de Haas, R. R., Riedlinger, G. M., & 28 others , 29 Sept 2022, In: NATURE. 609, 7929, p. E13Research output: Contribution to journal › Comment/Letter to the editor › Academic
- All publications